Oveporexton confers symptomatic, functional, cognitive benefits in narcolepsy type 1
10 Aug 2026
bởiJairia Dela Cruz
Treatment with the oral orexin receptor 2 (OX2R) agonist oveporexton improves symptom control, daily function, and cognitive outcomes in patients with narcolepsy type 1, according to pooled data from two phase III studies, The First Light and The Radiant Light.
Oveporexton confers symptomatic, functional, cognitive benefits in narcolepsy type 1
10 Aug 2026